Australia markets closed

EGRX Dec 2022 50.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
9.630.00 (0.00%)
As of 02:35PM EDT. Market open.
Full screen
Previous close9.63
Open9.63
Bid4.80
Ask9.00
Strike50.00
Expiry date2022-12-16
Day's range9.63 - 9.63
Contract rangeN/A
Volume1
Open interest1
  • GlobeNewswire

    Federal Circuit Rules in Favor of Eagle Pharmaceuticals in Vasopressin Litigation

    WOODCLIFF LAKE, N.J., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the U.S. District Court for the District of Delaware’s decision that Eagle’s vasopressin product does not infringe on any of the patents asserted by Par Pharmaceutical, Inc. (“Par”). Par previously sued Eagle in 2018, alleging infringement of several of its patents and a trial was held in July

  • Simply Wall St.

    Time To Worry? Analysts Are Downgrading Their Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Outlook

    The latest analyst coverage could presage a bad day for Eagle Pharmaceuticals, Inc. ( NASDAQ:EGRX ), with the analysts...

  • Motley Fool

    Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call Transcript

    At this time, I would like to welcome everyone to the Eagle Pharmaceuticals second quarter 2022 financial results. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, investor relations for Eagle Pharmaceuticals. This is Lisa Wilson, investor relations for Eagle Pharmaceuticals.